Geron | GERN - Operating Profit

Stock Price
1.47
Daily Change
-0.04 -2.65%
Monthly
11.36%
Yearly
-51.32%
Q1 Forecast
1.33

Geron reported $-13.89M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Amgen USD 3.96B 464M Dec/2025
Bio Techne USD 54.46M 6.8M Dec/2025
Cassava Sciences USD -11.86M 2.23M Sep/2025
Cytokinetics USD -166.76M 55.25M Sep/2025
Exelixis USD 256.36M 42.78M Sep/2025
Genmab DKK 360M 172M Jun/2025
Geron USD -13.89M 1.43M Sep/2025
Gilead Sciences USD 3.51B 810M Sep/2025
Incyte USD 431.31M 120.49M Sep/2025
MacroGenics USD 18.64M 55.4M Sep/2025
Novartis USD 4.5B 363M Sep/2025